T-DM1 activity in metastatic HER2-positive breast cancers that received prior therapy with trastuzumab and pertuzumab.
Dzimitrowicz H, Berger M, Vargo C, Hood A, Abdelghany O, Raghavendra A, Tripathy D, Valero V, Pusztai L, Murthy R. T-DM1 activity in metastatic HER2-positive breast cancers that received prior therapy with trastuzumab and pertuzumab. Journal Of Clinical Oncology 2016, 34: 585-585. DOI: 10.1200/jco.2016.34.15_suppl.585.Peer-Reviewed Original ResearchMetastatic HER2-positive breast cancerHER2-positive breast cancerT-DM1 activityPrior therapyBreast cancerPertuzumabTrastuzumabTherapyCancer